• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Perioperative change in neutrophil-to-lymphocyte ratio (NLR) is a prognostic factor in patients with completely resected primary pulmonary sarcomatoid carcinoma.围手术期中性粒细胞与淋巴细胞比值(NLR)的变化是完全切除的原发性肺肉瘤样癌患者的一个预后因素。
J Thorac Dis. 2019 Mar;11(3):819-826. doi: 10.21037/jtd.2019.02.02.
2
The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer.术后中性粒细胞与淋巴细胞比值及其变化可预测Ⅰ期非小细胞肺癌完全切除术后的生存情况。
Onco Targets Ther. 2016 Oct 21;9:6529-6537. doi: 10.2147/OTT.S117290. eCollection 2016.
3
Prognostic utility of inflammation-based biomarkers, neutrophil-lymphocyte ratio and change in neutrophil-lymphocyte ratio, in surgically resected lung cancers.基于炎症的生物标志物、中性粒细胞与淋巴细胞比值及中性粒细胞与淋巴细胞比值变化在手术切除肺癌中的预后效用
Ann Thorac Med. 2021 Apr-Jun;16(2):148-155. doi: 10.4103/atm.ATM_382_20. Epub 2021 Feb 25.
4
Postoperative Elevations of Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios Predict Postoperative Pulmonary Complications in Non-small Cell Lung Cancer Patients: A Retrospective Cohort Study.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值升高与非小细胞肺癌患者术后肺部并发症的相关性:一项回顾性队列研究。
Curr Med Sci. 2020 Apr;40(2):339-347. doi: 10.1007/s11596-020-2189-x. Epub 2020 Apr 26.
5
Increasing neutrophil-to-lymphocyte ratio following radiation is a poor prognostic factor and directly correlates with splenic radiation dose in pancreatic cancer.放疗后中性粒细胞与淋巴细胞比值升高是预后不良的因素,并与胰腺癌脾脏受照剂量直接相关。
Radiother Oncol. 2021 May;158:207-214. doi: 10.1016/j.radonc.2021.02.035. Epub 2021 Mar 3.
6
Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 inhibitors.基线及中性粒细胞与淋巴细胞比值变化对接受PD-1抑制剂治疗且体能状态较差的晚期非小细胞肺癌患者生存的预后价值。
Transl Lung Cancer Res. 2021 Mar;10(3):1397-1407. doi: 10.21037/tlcr-21-43.
7
Clinical Significance of Dynamic Neutrophil-lymphocyte Ratio Changes in Patients With Colorectal Cancer.动态中性粒细胞-淋巴细胞比值变化对结直肠癌患者的临床意义。
Anticancer Res. 2020 Apr;40(4):2311-2317. doi: 10.21873/anticanres.14197.
8
Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection.完全切除术后Ⅰ期非小细胞肺癌患者术前中性粒细胞与淋巴细胞比值的预后意义
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1324-31. doi: 10.1245/s10434-015-4735-5. Epub 2015 Jul 22.
9
Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma.中性粒细胞与淋巴细胞比值的基线水平和变化对预测预后的意义:晚期胰腺导管腺癌的回顾性分析。
Sci Rep. 2017 Apr 9;7(1):753. doi: 10.1038/s41598-017-00859-5.
10
The post-treatment neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after treatment of stage III non-small-cell lung cancer with conventionally fractionated radiotherapy.治疗后中性粒细胞与淋巴细胞比值及比值变化可预测 III 期非小细胞肺癌常规分割放疗后的生存情况。
Future Oncol. 2020 Mar;16(9):439-449. doi: 10.2217/fon-2019-0837. Epub 2020 Mar 6.

引用本文的文献

1
Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review.肺肉瘤样癌的生物学特性及临床治疗:一项叙述性综述
Transl Lung Cancer Res. 2024 Mar 29;13(3):635-653. doi: 10.21037/tlcr-24-127. Epub 2024 Mar 27.
2
Quantifying causal effects from observed data using quasi-intervention.使用拟干预法从观测数据中量化因果效应。
BMC Med Inform Decis Mak. 2022 Dec 21;22(1):337. doi: 10.1186/s12911-022-02086-z.
3
The ımportance of ınflammatory parameters ın predıctıng deep sternal wound ınfectıons after open heart surgery.炎症参数在预测心脏直视手术后深部胸骨伤口感染中的重要性。
Rev Assoc Med Bras (1992). 2022 Sep;68(9):1185-1190. doi: 10.1590/1806-9282.20220140.
4
[Clinical analysis of 17 cases of sarcomatoid carcinoma of head and neck].17例头颈部肉瘤样癌的临床分析
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Feb;36(2):125-129. doi: 10.13201/j.issn.2096-7993.2022.02.010.
5
Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer.围手术期中性粒细胞与淋巴细胞比值升高提示结直肠癌患者预后不良。
J Inflamm Res. 2021 Sep 7;14:4457-4466. doi: 10.2147/JIR.S327443. eCollection 2021.
6
Dynamic Changes in Perioperative Cellular Inflammation and Acute Kidney Injury after Coronary Artery Bypass Grafting.冠状动脉旁路移植术后围手术期细胞炎症和急性肾损伤的动态变化。
Braz J Cardiovasc Surg. 2021 Jun 1;36(3):354-364. doi: 10.21470/1678-9741-2020-0163.
7
Survival Analysis and Prediction Model for Pulmonary Sarcomatoid Carcinoma Based on SEER Database.基于监测、流行病学和最终结果(SEER)数据库的肺肉瘤样癌生存分析及预测模型
Front Oncol. 2021 May 31;11:630885. doi: 10.3389/fonc.2021.630885. eCollection 2021.
8
Preoperative systemic immune-inflammation index predicts survival and recurrence in patients with resected primary pulmonary sarcomatoid carcinoma.术前全身免疫炎症指数可预测原发性肺肉瘤样癌切除患者的生存及复发情况。
Transl Lung Cancer Res. 2021 Jan;10(1):18-31. doi: 10.21037/tlcr-20-960.
9
Pulmonary sarcomatoid carcinoma: progress, treatment and expectations.肺肉瘤样癌:进展、治疗与展望。
Ther Adv Med Oncol. 2020 Aug 25;12:1758835920950207. doi: 10.1177/1758835920950207. eCollection 2020.
10
First-line albumin-bound paclitaxel/carboplatin plus apatinib in advanced pulmonary sarcomatoid carcinoma: A case series and review of the literature.一线白蛋白结合型紫杉醇/卡铂联合阿帕替尼治疗晚期肺肉瘤样癌:病例系列及文献综述
Medicine (Baltimore). 2020 Jun 5;99(23):e20667. doi: 10.1097/MD.0000000000020667.

本文引用的文献

1
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients.治疗后血液学参数的变化可预测非小细胞肺癌患者对nivolumab 单药治疗的反应。
PLoS One. 2018 Oct 25;13(10):e0197743. doi: 10.1371/journal.pone.0197743. eCollection 2018.
2
Sarcomatoid Carcinoma of the Lung Presenting as Localized Bronchiectasis: A Case Report and Review of Literature.表现为局限性支气管扩张的肺肉瘤样癌:一例报告并文献复习
Respir Med Case Rep. 2018 May 17;24:143-146. doi: 10.1016/j.rmcr.2018.05.016. eCollection 2018.
3
The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer.中性粒细胞与淋巴细胞比值的动态变化可预测 I-III 期结肠癌的临床结局。
Sci Rep. 2018 Jun 21;8(1):9453. doi: 10.1038/s41598-018-27896-y.
4
Neutrophil-to-lymphocyte Ratio (NLR) as a predictor for recurrence in patients with stage III melanoma.中性粒细胞与淋巴细胞比值(NLR)可预测 III 期黑色素瘤患者的复发。
Sci Rep. 2018 Mar 6;8(1):4044. doi: 10.1038/s41598-018-22425-3.
5
Persistent elevation of postoperative neutrophil-to-lymphocyte ratio: A better predictor of survival in gastric cancer than elevated preoperative neutrophil-to-lymphocyte ratio.术后中性粒细胞与淋巴细胞比值持续升高:比术前中性粒细胞与淋巴细胞比值升高更能预测胃癌患者的生存率。
Sci Rep. 2017 Oct 25;7(1):13967. doi: 10.1038/s41598-017-13969-x.
6
Clinicopathological factors influenced the prognosis of surgically resected pulmonary pleomorphic carcinoma.临床病理因素影响手术切除的肺多形性癌的预后。
J Thorac Dis. 2017 May;9(5):1295-1302. doi: 10.21037/jtd.2017.03.167.
7
Basal neutrophil-to-lymphocyte ratio is associated with overall survival in melanoma.基础中性粒细胞与淋巴细胞比值与黑色素瘤的总生存期相关。
Melanoma Res. 2017 Apr;27(2):140-144. doi: 10.1097/CMR.0000000000000333.
8
The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer.术后中性粒细胞与淋巴细胞比值及其变化可预测Ⅰ期非小细胞肺癌完全切除术后的生存情况。
Onco Targets Ther. 2016 Oct 21;9:6529-6537. doi: 10.2147/OTT.S117290. eCollection 2016.
9
Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients.中性粒细胞与淋巴细胞比值在肺癌中的预后作用:一项纳入7054例患者的荟萃分析
Onco Targets Ther. 2015 Sep 29;8:2731-8. doi: 10.2147/OTT.S90875. eCollection 2015.
10
The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.根治性膀胱切除术治疗膀胱尿路上皮癌患者术后早期中性粒细胞与淋巴细胞比值的预后意义
Ann Surg Oncol. 2016 Jan;23(1):335-42. doi: 10.1245/s10434-015-4708-8. Epub 2015 Jul 8.

围手术期中性粒细胞与淋巴细胞比值(NLR)的变化是完全切除的原发性肺肉瘤样癌患者的一个预后因素。

Perioperative change in neutrophil-to-lymphocyte ratio (NLR) is a prognostic factor in patients with completely resected primary pulmonary sarcomatoid carcinoma.

作者信息

Seong Yong Won, Han Sung Joon, Jung Woohyun, Jeon Jae Hyun, Cho Sukki, Jheon Sanghoon, Kim Kwhanmien

机构信息

Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.

出版信息

J Thorac Dis. 2019 Mar;11(3):819-826. doi: 10.21037/jtd.2019.02.02.

DOI:10.21037/jtd.2019.02.02
PMID:31019770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6462731/
Abstract

BACKGROUND

There has been controversy regarding prognostic factors for surgically resected primary pulmonary sarcomatoid carcinoma (PSC). Recently, several studies have shown that neutrophil-to-lymphocyte ratio (NLR) was a prognostic factor for various types of cancers from multiple organs. Therefore, we performed this study to evaluate whether NLR is related to prognosis after complete surgical resection of primary PSC.

METHODS

From Oct. 2003 to Sep. 2015, a total of 50 patients underwent surgical resection for primary PSC. After excluding patients with any history of other malignancy and incompletely resected cases, a total of 37 patients were included, and data were retrospectively collected and analyzed. Change in postoperative NLR and the initial NLR (ΔNLR) was calculated from the perioperative complete blood count (CBC) results.

RESULTS

Mean age of the cohort was 62.2±1.9 years, and 31 patients (83.8%) were male. Twenty patients (54.1%) were revealed as pN0. Overall 5-year survival rate was 50.3%. Seventeen patients (45.9%) had locoregional or distant metastases. Univariate survival analysis revealed age >70, ΔNLR >17 as risk factors for overall survival (P=0.009, 0.005) and disease-free survival (P=0.036, 0.018). Multivariate Cox-regression analysis revealed age >70 and ΔNLR >17 as independent risk factors for overall survival and ΔNLR >17 as the only independent risk factor for the disease-free survival.

CONCLUSIONS

In patients with completely resected primary PSC, perioperative ΔNLR had a significant effect on the overall survival and disease-free survival. Older age was also an independent risk factor for overall survival.

摘要

背景

对于手术切除的原发性肺肉瘤样癌(PSC)的预后因素一直存在争议。最近,多项研究表明中性粒细胞与淋巴细胞比值(NLR)是多种器官不同类型癌症的预后因素。因此,我们进行了这项研究,以评估NLR是否与原发性PSC完全手术切除后的预后相关。

方法

2003年10月至2015年9月,共有50例患者接受了原发性PSC的手术切除。排除有其他恶性肿瘤病史和切除不完全的病例后,共纳入37例患者,并对数据进行回顾性收集和分析。根据围手术期全血细胞计数(CBC)结果计算术后NLR的变化和初始NLR(ΔNLR)。

结果

该队列的平均年龄为62.2±1.9岁,31例患者(83.8%)为男性。20例患者(54.1%)为pN0。总体5年生存率为50.3%。17例患者(45.9%)有局部或远处转移。单因素生存分析显示年龄>70岁、ΔNLR>17是总生存(P=0.009,0.005)和无病生存(P=0.036,0.018)的危险因素。多因素Cox回归分析显示年龄>70岁和ΔNLR>17是总生存的独立危险因素,ΔNLR>17是无病生存的唯一独立危险因素。

结论

在原发性PSC完全切除的患者中,围手术期ΔNLR对总生存和无病生存有显著影响。高龄也是总生存的独立危险因素。